Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cortex Pharmaceuticals
Irvine, California, United Statescortex.io ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cortex merged with Pier Pharmaceuticals in 2012 to focus on brain-controlled breathing disorders. Its lead programs included CX1739 for opiate-induced respiratory depression and central sleep apnea, and dronabinol for obstructive sleep apnea. Both were in Phase 2 clinical development at the time of the merger. The company’s future status post-merger as an independent entity appears unclear; it may have ceased operations or been absorbed fully into another structure[6].
- Therapeutic areas
- Pulmonology
- Modalities
- Small moleculeSynthetic cannabinoid
- Industry
- Biotech
02
Partnerships
Alkermes Inc. previously licensed calpain inhibitor technology from Cortex but this agreement ended before the company's later focus on breathing disorders[9]. No major pharma partnerships reported for current assets.
Beyond the preview
Go deeper on Cortex Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cortex Pharmaceuticals.